143 related articles for article (PubMed ID: 37178856)
1. Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women.
Tan-Kim J; Shah NM; Do D; Menefee SA
Am J Obstet Gynecol; 2023 Aug; 229(2):143.e1-143.e9. PubMed ID: 37178856
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.
Torella M; Del Deo F; Grimaldi A; Iervolino SA; Pezzella M; Tammaro C; Gallo P; Rappa C; De Franciscis P; Colacurci N
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():125-128. PubMed ID: 27838537
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT.
Harding C; Chadwick T; Homer T; Lecouturier J; Mossop H; Carnell S; King W; Abouhajar A; Vale L; Watson G; Forbes R; Currer S; Pickard R; Eardley I; Pearce I; Thiruchelvam N; Guerrero K; Walton K; Hussain Z; Lazarowicz H; Ali A
Health Technol Assess; 2022 May; 26(23):1-172. PubMed ID: 35535708
[TBL] [Abstract][Full Text] [Related]
5. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors.
Brown JS; Vittinghoff E; Kanaya AM; Agarwal SK; Hulley S; Foxman B;
Obstet Gynecol; 2001 Dec; 98(6):1045-52. PubMed ID: 11755552
[TBL] [Abstract][Full Text] [Related]
6. Vaginal Estrogen as First-Line Therapy for Recurrent Urinary Tract Infections in Postmenopausal Women and Risk Factors for Needing Additional Therapy.
Chang E; Kent L; Prieto I; Eggers E; Tanner JP; Bassaly R; Wyman A; Greene K
Female Pelvic Med Reconstr Surg; 2021 Mar; 27(3):e487-e492. PubMed ID: 33620909
[TBL] [Abstract][Full Text] [Related]
7. Predictors of urinary incontinence in a prospective cohort of postmenopausal women.
Jackson SL; Scholes D; Boyko EJ; Abraham L; Fihn SD
Obstet Gynecol; 2006 Oct; 108(4):855-62. PubMed ID: 17012446
[TBL] [Abstract][Full Text] [Related]
8. Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial.
Ferrante KL; Wasenda EJ; Jung CE; Adams-Piper ER; Lukacz ES
Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):112-117. PubMed ID: 31232721
[TBL] [Abstract][Full Text] [Related]
9. The Influence of a Community Pharmacy Automatic Prescription Refill Program on Medicare Part D Adherence Metrics.
Lester CA; Mott DA; Chui MA
J Manag Care Spec Pharm; 2016 Jul; 22(7):801-7. PubMed ID: 27348281
[TBL] [Abstract][Full Text] [Related]
10. Predictors of urinary tract infection after menopause: a prospective study.
Jackson SL; Boyko EJ; Scholes D; Abraham L; Gupta K; Fihn SD
Am J Med; 2004 Dec; 117(12):903-11. PubMed ID: 15629728
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of systemic estrogen for preventing urinary tract infections in postmenopausal women.
Fox KA; Lokken EM; Reed SD; Rahn DD
Menopause; 2021 May; 28(7):836-844. PubMed ID: 33973539
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for mesh erosion after vaginal sling procedures for urinary incontinence.
Kokanali MK; Doğanay M; Aksakal O; Cavkaytar S; Topçu HO; Özer İ
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():146-50. PubMed ID: 24793930
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
[TBL] [Abstract][Full Text] [Related]
14. [Local estrogen therapy--clinical implications--2012 update].
Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
[TBL] [Abstract][Full Text] [Related]
15. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
[TBL] [Abstract][Full Text] [Related]
16. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.
Eriksen B
Am J Obstet Gynecol; 1999 May; 180(5):1072-9. PubMed ID: 10329858
[TBL] [Abstract][Full Text] [Related]
17. Estrogen for the prevention of recurrent urinary tract infections in postmenopausal women: a meta-analysis of randomized controlled trials.
Chen YY; Su TH; Lau HH
Int Urogynecol J; 2021 Jan; 32(1):17-25. PubMed ID: 32564121
[TBL] [Abstract][Full Text] [Related]
18. The role of estrogens in female lower urinary tract dysfunction.
Robinson D; Cardozo LD
Urology; 2003 Oct; 62(4 Suppl 1):45-51. PubMed ID: 14550837
[TBL] [Abstract][Full Text] [Related]
19. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women.
Perrotta C; Aznar M; Mejia R; Albert X; Ng CW
Cochrane Database Syst Rev; 2008 Apr; (2):CD005131. PubMed ID: 18425910
[TBL] [Abstract][Full Text] [Related]
20. The Role of Chronic Mesh Infection in Delayed-Onset Vaginal Mesh Complications or Recurrent Urinary Tract Infections: Results From Explanted Mesh Cultures.
Mellano EM; Nakamura LY; Choi JM; Kang DC; Grisales T; Raz S; Rodriguez LV
Female Pelvic Med Reconstr Surg; 2016; 22(3):166-71. PubMed ID: 26829350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
